Skip to main content

Table 3 Summary of trajectory evaluation from intrafractional prostate monitoring: mean, standard deviation and maximum displacement values

From: Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking

Treatment phase

Displacement (mm)

Directions

Lateral

Longitudinal

Vertical

Setup

Mean

 − 0.20 ± 0.45

 − 0.07 ± 0.74

 − 0.21 ± 0.81

Maximum

4.88

7.75

17.73

Dose delivery

Mean

 − 0.14 ± 0.41

0.15 ± 0.70

 − 0.33 ± 0.73

Maximum

3.09

5.23

12.74

Global treatment

Mean

 − 0.18 ± 0.46

0.01 ± 0.77

 − 0.26 ± 0.82

Maximum

4.88

6.20

17.73